Increased expression of costimulatory markers CD134 and CD80 on IL-17 producing T-cells in patients with systemic lupus erythematosus

[1]  S. Ito,et al.  Laser microdissection‐based analysis of cytokine balance in the kidneys of patients with lupus nephritis , 2010, Clinical and experimental immunology.

[2]  Gang Wang,et al.  The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. , 2009, Rheumatology.

[3]  G. Tsokos,et al.  Human TCR-αβ+ CD4− CD8− T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype1 , 2009, The Journal of Immunology.

[4]  G. Tsokos,et al.  The Role of IL-23/IL-17 Axis in Lupus Nephritis1 , 2009, The Journal of Immunology.

[5]  J. Goodall,et al.  Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[6]  U. Panzer,et al.  The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. , 2009, Journal of the American Society of Nephrology : JASN.

[7]  Ming Li,et al.  Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[8]  Manuel Rubio,et al.  CD28 Co-Stimulation Down Regulates Th17 Development , 2009, PloS one.

[9]  Yan-bin Zhou,et al.  Targeting the CD134–CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis , 2009, Rheumatology International.

[10]  M. Oukka,et al.  Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1 , 2008, The Journal of Immunology.

[11]  A. Kribben,et al.  CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  C. Kallenberg,et al.  Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. , 2008, Arthritis and rheumatism.

[13]  C. Lam,et al.  Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. , 2008, Clinical immunology.

[14]  S. Brand,et al.  Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL‐22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status , 2008, Inflammatory bowel diseases.

[15]  J. Farber,et al.  Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR61 , 2008, The Journal of Immunology.

[16]  Erin G Harper,et al.  Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines , 2007, Current rheumatology reports.

[17]  Nathalie Arbour,et al.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.

[18]  L. Cosmi,et al.  Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.

[19]  Susan E. Murray,et al.  OX40-Mediated Differentiation to Effector Function Requires IL-2 Receptor Signaling but Not CD28, CD40, IL-12Rβ2, or T-bet1 , 2007, The Journal of Immunology.

[20]  A. Kribben,et al.  CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus , 2006, Clinical and experimental immunology.

[21]  A. Weinberg,et al.  OX40 (CD134) engagement drives differentiationof CD4+ T cells to effector cells , 2006, European journal of immunology.

[22]  R. Pirskanen,et al.  Expression of OX40 (CD134) on CD4+ T‐cells from patients with myasthenia gravis , 2006, Clinical and experimental immunology.

[23]  A. Weinberg,et al.  A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions1 , 2004, The Journal of Immunology.

[24]  R. Perricone,et al.  T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen. , 2001, Clinical and experimental rheumatology.

[25]  H. Friess,et al.  IL-17 Stimulates Intraperitoneal Neutrophil Infiltration Through the Release of GROα Chemokine from Mesothelial Cells1 , 2000, The Journal of Immunology.

[26]  M. Daha,et al.  Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. , 2000, Journal of the American Society of Nephrology : JASN.

[27]  J. Weening,et al.  Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. , 2000, Journal of the American Society of Nephrology : JASN.

[28]  P. Miossec,et al.  Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. , 1999, Arthritis and rheumatism.

[29]  J. Lötvall,et al.  Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.

[30]  J. Ragnaud,et al.  Th1 (IL‐2, interferon‐gamma (IFN‐γ)) and Th2 (IL‐10, IL‐4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) , 1999, Clinical and experimental immunology.

[31]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[32]  Li Li,et al.  Negative regulation of IL-17 production by OX40/OX40L interaction. , 2008, Cellular immunology.

[33]  Sun Yat-sen,et al.  Expression and Role of CD134 and NF-KB in Renal Tissue of Lupus Nephritis , 2003 .